These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12373606)

  • 1. Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells.
    Kato K; Hitomi Y; Imamura K; Esumi H
    Br J Cancer; 2002 Oct; 87(8):898-904. PubMed ID: 12373606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
    Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
    Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
    Aoki K; Yoshida T; Sugimura T; Terada M
    Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
    Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
    J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combinational effects of K-ras and IGF-IR antisense oligodeoxynucleotide on proliferation and apoptosis of human pancreatic cancer Patu8988 cells].
    Shen YM; Yang XC; Zhang MH; Shen JK; Sun YH
    Ai Zheng; 2008 May; 27(5):496-504. PubMed ID: 18479599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
    Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
    Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
    Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
    Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
    FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
    Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
    Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide treatment of ras-induced tumors in nude mice.
    Wickstrom E
    Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
    Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
    Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of malignant cell phenotype of human pancreatic adenocarcinoma cell line by recombinant retroviral vector expressing antisense Ki-ras].
    Li H; Wang Z; Liu T
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):288-91. PubMed ID: 8745475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the 5' splice site mutation in the Nagase analbuminemic rat with mutated U1snRNA.
    Hitomi Y; Sugiyama K; Esumi H
    Biochem Biophys Res Commun; 1998 Oct; 251(1):11-6. PubMed ID: 9790899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
    Wang YX; Gao L; Ji ZZ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
    Mukhopadhyay T; Tainsky M; Cavender AC; Roth JA
    Cancer Res; 1991 Mar; 51(6):1744-8. PubMed ID: 1998965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells.
    Alemany R; Ruan S; Kataoka M; Koch PE; Mukhopadhyay T; Cristiano RJ; Roth JA; Zhang WW
    Cancer Gene Ther; 1996; 3(5):296-301. PubMed ID: 8894248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.